本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tetraphase Pharmaceuticals Inc.

2.20
0.0000
成交量:- -
成交額:- -
市值:1,597.91萬
市盈率:-0.17
高:2.20
開:2.20
低:2.20
收:2.20
資料載入中...
2020/07/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/29

重要事件披露

8-K - Current report
2020/07/28

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/07/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/30

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/24

重要事件披露

8-K - Current report
2020/06/22

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/22

重要事件披露

8-K - Current report
2020/06/11

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/05

重要事件披露

8-K - Current report
2020/06/04

重要事件披露

8-K - Current report
2020/06/01

重要事件披露

8-K - Current report
2020/06/01

企業合併公告

425 - Prospectuses and communications, business combinations
2020/05/29

企業合併公告

425 - Prospectuses and communications, business combinations
2020/05/29

重要事件披露

8-K - Current report
2020/05/29

企業合併公告

425 - Prospectuses and communications, business combinations
2020/05/28

重要事件披露

8-K - Current report
2020/05/28

企業合併公告

425 - Prospectuses and communications, business combinations
2020/05/27

企業合併公告

425 - Prospectuses and communications, business combinations